Tyra Biosciences annual current ratio
2020
2021
2022
2023
2024
2025
Tyra Biosciences Current Ratio Growth & History (TYRA)
Tyra Biosciences's current ratio was 14.67 for fiscal 2025.
View full Tyra Biosciences company overviewTyra Biosciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 14.67 | −9.14 | −38.38% |
| 2024 | 2024-12-31 | 23.81 | 10.00 | +72.46% |
| 2023 | 2023-12-31 | 13.80 | −31.33 | −69.41% |
| 2022 | 2022-12-31 | 45.13 | −38.96 | −46.33% |
| 2021 | 2021-12-31 | 84.09 | 75.86 | +922.40% |
| 2020 | 2020-12-31 | 8.22 | — | — |
Tyra Biosciences quarterly current ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 14.91 | −7.04 | −32.07% |
| Q1 2026 | 2026-03-31 | 20.49 | −2.29 | −10.05% |
| Q4 2025 | 2025-12-31 | 14.67 | −9.14 | −38.38% |
| Q3 2025 | 2025-09-30 | 17.71 | −11.84 | −40.07% |
| Q2 2025 | 2025-06-30 | 21.94 | −14.52 | −39.82% |
| Q1 2025 | 2025-03-31 | 22.78 | −22.05 | −49.18% |
| Q4 2024 | 2024-12-31 | 23.81 | 10.00 | +72.46% |
| Q3 2024 | 2024-09-30 | 29.55 | 7.41 | +33.48% |
| Q2 2024 | 2024-06-30 | 36.46 | −8.08 | −18.13% |
| Q1 2024 | 2024-03-31 | 44.83 | −22.17 | −33.09% |
| Q4 2023 | 2023-12-31 | 13.80 | −31.33 | −69.41% |
| Q3 2023 | 2023-09-30 | 22.14 | −26.59 | −54.57% |
| Q2 2023 | 2023-06-30 | 44.54 | −6.29 | −12.38% |
| Q1 2023 | 2023-03-31 | 67.00 | 7.01 | +11.69% |
| Q4 2022 | 2022-12-31 | 45.13 | −38.96 | −46.33% |
| Q3 2022 | 2022-09-30 | 48.73 | −17.02 | −25.89% |
| Q2 2022 | 2022-06-30 | 50.83 | — | — |
| Q1 2022 | 2022-03-31 | 59.99 | — | — |
| Q4 2021 | 2021-12-31 | 84.09 | 75.86 | +922.40% |
| Q3 2021 | 2021-09-30 | 65.75 | — | — |
| Q4 2020 | 2020-12-31 | 8.22 | — | — |
Tyra Biosciences current ratio trends
Over the last five fiscal years, Tyra Biosciences's current ratio increased from 8.22 to 14.67, a change of 6.45. The latest reported quarter, Q2 2026, shows 14.91.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tyra Biosciences source filings ↗